Amplifon | AMP - Ebit

Aktienkurs
10.73
Täglich Wechseln
0.05 0.47%
Monatlich
14.17%
Jährlich
-45.43%
Q2 Prognose
10.67




Ebit Veränderung Datum
Amplifon EUR 44M 17.72M 2025-12
Avanos Medical USD 8.9M 15.87M 2026-03
Brookdale Senior Living USD 27.38M 82.1M 2025-12
Cencora USD 1.02B 1.09B 2025-12
Diasorin EUR 56M 8.57M 2026-03
Encompass Health USD 319.1M 35.7M 2026-03
Enovis USD 9.24M 6.8M 2026-03
GE HealthCare Technologies USD 878M 124M 2025-12
OPKO Health USD -38.32M 91.11M 2025-12
Pediatrix Medical Group USD 54.67M 19.33M 2025-12
Veradigm USD -45.47M 70.47M 2022-12
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03